細胞分離市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、細胞類型、技術、應用、地區和競爭格局分類，2021-2031年

全球細胞分離市場預計將從 2025 年的 91.2 億美元大幅成長至 2031 年的 154.7 億美元，複合年成長率高達 9.21%。

該市場涵蓋了從血液和組織等複雜生物檢體中分離特定細胞群所需的各種技術和產品，確保細胞的高純度和活性，以滿足後續應用的需求。推動這一市場成長的主要因素是腫瘤學研究的拓展和慢性病發病率的上升，這兩者都需要精準的細胞分離技術來推動個人化免疫療法和先進診斷技術的發展。例如，美國癌症協會預測，到2025年，美國將新增約2,041,910例癌症病例，凸顯了高效細胞分離工作流程的迫切需求，以加強針對複雜惡性腫瘤的臨床試驗和轉化研究。

儘管市場成長前景可觀，但先進細胞分離設備和試劑級耗材的高昂成本為市場帶來了巨大挑戰。這些高額支出會嚴重影響學術機構和小規模實驗室的預算，這可能會阻礙自動化解決方案的廣泛應用。因此，這種經濟障礙可能會限制市場擴張，尤其是在價格敏感地區，迫使一些終端用戶依賴效率較低的手動分離方法，而這些方法既限制了處理能力，也限制了擴充性。

市場促進因素

細胞和基因治療研究的快速發展是全球細胞分離市場的主要驅動力，從根本上改變了產業的重心，使其從學術探索轉向商業化生產。隨著嵌合體抗原受體（CAR）T細胞療法和其他再生醫學的開發平臺不斷擴展，製造商越來越需要先進的分離技術來確保目標細胞的純度和活性，這對於患者安全和治療效果至關重要。這種向工業級加工的轉變正在推動基礎設施的大量投資，一個典型的例子是Kite Pharma於2025年12月投資1.85億歐元，用於擴建其位於荷蘭的先進細胞治療生產設施，並支持在歐洲範圍內永續的大規模生產。

此外，生物製藥研發投入的增加顯著加快了產品上市速度，為高通量自動化分離系統提供了必要的資金。製藥業領導者正投入大量資金進行研發，以加速藥物發現流程，這些流程高度依賴精確的細胞分離技術進行標靶識別和毒性篩檢。根據Fierce Biotech 2025年3月發布的出版報告《2024年研發預算排名前十的製藥公司》，默克以約179億美元的研發支出領先業界。這筆資金不僅支持目前的研發流程，也為未來的產能擴張提供了資金。例如，諾華公司在2025年宣布，計劃在未來五年內投資230億美元，以加強其生產和研發基礎設施，包括基因治療和細胞治療平台。

市場挑戰

全球細胞分離市場面臨巨大的擴張障礙，這主要是由於先進設備和高品質耗材需要大量的資本投入。這些飆升的採購和營運成本對學術機構和小規模生技公司造成了特別嚴重的衝擊，因為它們通常面臨預算緊張的困境。由於資金有限，這些小規模機構往往難以負擔自動化分離系統，這種經濟現實迫使研究人員繼續使用手動分離方法。這種對手動操作的依賴必然會限制實驗的處理能力和一致性，從而降低市場對高階產品的整體需求。

近期的投資趨勢進一步凸顯了該產業面臨的嚴峻財務困境。例如，生物技術創新組織（BIO）報告稱，到2025年，生物技術新創企業的資金籌措將從第一季的26億美元大幅下降至第二季的9億美元。資金池的萎縮直接限制了新興企業的購買力，導致關鍵設備升級的延遲或取消。因此，注重成本的終端用戶無法投資自動化解決方案，阻礙了市場有效滲透關鍵研究領域的能力，並減緩了技術普及的整體步伐。

市場趨勢

市場正日益重視影像導引和人工智慧增強型細胞分選技術的商業化，推動著從傳統的螢光分析轉向高維度形態學評估的根本性轉變。這項技術進步將使研究人員能夠基於傳統標記無法檢測到的物理和空間特徵來分離細胞群，從而為表現型藥物發現和品管開闢新的可能性。這一趨勢主要得益於旨在將這些前沿技術創新推廣至全球的非稀釋性資金。例如，ThinkCyte於2025年8月宣布，已獲得NEDO獨角獸基金高達30億日圓（約2000萬美元）的津貼，用於加速其人工智慧驅動的細胞表徵和分選平台的擴展。

同時，為克服高壓分選方法可能損害細胞活性的局限性，無標定和微創分離技術的應用顯著增加。利用浮力、微氣泡或聲波等原理的技術正受到廣泛關注，因為它們能夠維持脆弱生物樣本的生理完整性，這對於再生醫學和功能分析等下游應用至關重要。這種向更溫和的分離方法的轉變吸引了大量創業投資，以支持臨床級生產和業務規模化。例如，2025年6月，Akadeum Life Sciences成功資金籌措了超過2000萬美元的資金，用於支持其專有的基於浮力的細胞分離技術的業務拓展和臨床試驗。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球細胞分離市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品分類（耗材、設備）
  • 細胞類型（人類細胞、動物細胞）
  • 透過技術（離心、表面標誌物、過濾）
  • 依應用領域（生物分子分離、癌症研究、幹細胞研究、組織再生、體外診斷和治療）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美細胞分離市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲細胞分離市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區細胞分離市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東與非洲細胞分離市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美細胞分離市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球細胞分離市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Akadeum Life Sciences, Inc.
• Corning Inc.
• Merck & Co., Inc.
• STEMCELL Technologies Canada Inc.
• Bio-Rad Laboratories, Inc.
• Terumo Corp.
• Becton, Dickinson and Company
• Agilent Technologies, Inc.
• Danaher Corporation
• Thermo Fisher Scientific, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Cell Separation Market is projected to expand significantly, rising from USD 9.12 Billion in 2025 to USD 15.47 Billion by 2031, demonstrating a robust CAGR of 9.21%. This market encompasses various technologies and products crucial for isolating specific cell populations from complex biological samples like blood or tissue, ensuring their high purity and viability for subsequent applications. Growth is primarily fueled by the expanding landscape of oncology research and the increasing incidence of chronic diseases, both of which demand precise cell isolation for advancing personalized immunotherapies and sophisticated diagnostics. For instance, the American Cancer Society anticipates approximately 2,041,910 new cancer cases in the United States in 2025, highlighting an urgent need for efficient cell separation workflows to bolster clinical trials and translational research focused on complex malignancies.

Despite this promising growth, the market faces a considerable challenge stemming from the substantial capital required for advanced cell separation instruments and reagent-grade consumables. These high expenditures can severely constrain the budgets of academic institutions and smaller research laboratories, potentially hindering the widespread adoption of automated solutions. Consequently, this financial barrier could limit market expansion, particularly in price-sensitive regions, compelling some end-users to rely on less efficient manual separation methods that restrict both throughput and scalability.

Market Driver

The rapid expansion of cell and gene therapy research serves as a primary catalyst for the Global Cell Separation Market, fundamentally shifting the industry's focus from academic exploration towards commercial-scale manufacturing. As the development pipeline for chimeric antigen receptor (CAR) T-cell therapies and other regenerative medicines grows, manufacturers increasingly require sophisticated isolation technologies to guarantee the purity and viability of target cells, which are critical for patient safety and treatment efficacy. This transition to industrial-grade processing is driving substantial investment in infrastructure, exemplified by Kite Pharma's December 2025 expansion of its advanced cell therapy manufacturing facility in the Netherlands, reaching a total investment of €185 million to support sustainable, large-scale production across Europe.

Furthermore, increasing investments in biopharmaceutical research and development significantly accelerate market adoption by supplying the necessary capital for high-throughput and automated separation systems. Pharmaceutical leaders are dedicating vast resources to R&D to expedite drug discovery workflows, which heavily depend on precise cell isolation for target identification and toxicology screening. According to Fierce Biotech's March 2025 report on 'Top 10 pharma R&D budgets in 2024', Merck & Co. led the sector with an R&D expenditure of approximately $17.9 billion. This financial influx not only supports current workflows but also funds the expansion of future capabilities, as demonstrated by Novartis's 2025 announcement of a planned $23 billion investment over five years to enhance its manufacturing and research infrastructure, including platforms for gene and cell therapy.

Market Challenge

The Global Cell Separation Market faces a formidable barrier to expansion due to the substantial capital investment required for advanced instruments and high-grade consumables. These elevated procurement and operational costs disproportionately affect academic institutions and small-scale biotechnology firms, which frequently operate within stringent budgetary limitations. When funding is scarce, these smaller entities often cannot justify acquiring automated separation systems, a financial reality that forces researchers to continue with manual isolation methods. This reliance on manual processes inherently limits experimental throughput and consistency, thereby reducing overall demand for premium market offerings.

Recent investment trends further underscore the severity of these fiscal constraints within the industry. For instance, the Biotechnology Innovation Organization reported in 2025 that biotech startup funding decreased significantly from $2.6 billion in the first quarter to $900 million in the second quarter. This contraction in available capital directly curtails the purchasing power of emerging companies, leading to delays or cancellations of essential equipment upgrades. Consequently, the inability of cost-conscious end-users to invest in automated solutions hinders the market's capacity to effectively penetrate crucial research segments and slows the overall rate of technological adoption.

Market Trends

The market is increasingly prioritizing the commercialization of image-guided and AI-enhanced cell sorting technologies, marking a fundamental shift from traditional fluorescence-only analysis towards high-dimensional morphological assessment. This technological progression empowers researchers to isolate cell populations based on physical traits and spatial features that conventional markers cannot detect, thereby unlocking new capabilities in phenotypic drug discovery and quality control. This trend is substantially bolstered by non-dilutive funding designed to scale these deep-tech innovations globally, as exemplified by ThinkCyte's August 2025 announcement of being awarded a NEDO Unicorn Grant of up to 3 billion yen (approximately $20 million) to accelerate the business expansion of its AI-driven cell characterization and sorting platform.

Simultaneously, there is a distinct surge in the adoption of label-free and gentle separation techniques, developed to overcome the limitations of high-pressure sorting methods that often compromise cell viability. Technologies employing principles such as buoyancy, microbubbles, or acoustic waves are gaining traction because they preserve the physiological integrity of fragile biological samples, which is a critical requirement for downstream applications in regenerative medicine and functional assays. This move towards gentler isolation modalities is attracting significant venture capital to support clinical-grade manufacturing and operational scaling, as evidenced by Akadeum Life Sciences securing over $20 million in funding in June 2025 to expand its commercial operations and support clinical trials utilizing its proprietary buoyancy-based cell separation technology.

Key Market Players

• Akadeum Life Sciences, Inc.
• Corning Inc.
• Merck & Co., Inc.
• STEMCELL Technologies Canada Inc.
• Bio-Rad Laboratories, Inc.
• Terumo Corp.
• Becton, Dickinson and Company
• Agilent Technologies, Inc.
• Danaher Corporation
• Thermo Fisher Scientific, Inc.

Report Scope

In this report, the Global Cell Separation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Separation Market, By Product

• Consumables
• Instruments

Cell Separation Market, By Cell Type

• Human Cells
• Animal Cells

Cell Separation Market, By Technique

• Centrifugation
• Surface Marker
• Filtration

Cell Separation Market, By Application

• Biomolecule Isolation
• Cancer Research
• Stem Cell Research
• Tissue Regeneration
• In Vitro Diagnostics & Therapeutics

Cell Separation Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Separation Market.

Available Customizations:

Global Cell Separation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Separation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables, Instruments)
  • 5.2.2. By Cell Type (Human Cells, Animal Cells)
  • 5.2.3. By Technique (Centrifugation, Surface Marker, Filtration)
  • 5.2.4. By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics & Therapeutics)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Cell Separation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Cell Type
  • 6.2.3. By Technique
  • 6.2.4. By Application
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cell Separation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Cell Type
      • 6.3.1.2.3. By Technique
      • 6.3.1.2.4. By Application
  • 6.3.2. Canada Cell Separation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Cell Type
      • 6.3.2.2.3. By Technique
      • 6.3.2.2.4. By Application
  • 6.3.3. Mexico Cell Separation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Cell Type
      • 6.3.3.2.3. By Technique
      • 6.3.3.2.4. By Application

7. Europe Cell Separation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Cell Type
  • 7.2.3. By Technique
  • 7.2.4. By Application
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cell Separation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Cell Type
      • 7.3.1.2.3. By Technique
      • 7.3.1.2.4. By Application
  • 7.3.2. France Cell Separation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Cell Type
      • 7.3.2.2.3. By Technique
      • 7.3.2.2.4. By Application
  • 7.3.3. United Kingdom Cell Separation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Cell Type
      • 7.3.3.2.3. By Technique
      • 7.3.3.2.4. By Application
  • 7.3.4. Italy Cell Separation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Cell Type
      • 7.3.4.2.3. By Technique
      • 7.3.4.2.4. By Application
  • 7.3.5. Spain Cell Separation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Cell Type
      • 7.3.5.2.3. By Technique
      • 7.3.5.2.4. By Application

8. Asia Pacific Cell Separation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Cell Type
  • 8.2.3. By Technique
  • 8.2.4. By Application
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Cell Separation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Cell Type
      • 8.3.1.2.3. By Technique
      • 8.3.1.2.4. By Application
  • 8.3.2. India Cell Separation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Cell Type
      • 8.3.2.2.3. By Technique
      • 8.3.2.2.4. By Application
  • 8.3.3. Japan Cell Separation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Cell Type
      • 8.3.3.2.3. By Technique
      • 8.3.3.2.4. By Application
  • 8.3.4. South Korea Cell Separation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Cell Type
      • 8.3.4.2.3. By Technique
      • 8.3.4.2.4. By Application
  • 8.3.5. Australia Cell Separation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Cell Type
      • 8.3.5.2.3. By Technique
      • 8.3.5.2.4. By Application

9. Middle East & Africa Cell Separation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Cell Type
  • 9.2.3. By Technique
  • 9.2.4. By Application
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Cell Separation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Cell Type
      • 9.3.1.2.3. By Technique
      • 9.3.1.2.4. By Application
  • 9.3.2. UAE Cell Separation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Cell Type
      • 9.3.2.2.3. By Technique
      • 9.3.2.2.4. By Application
  • 9.3.3. South Africa Cell Separation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Cell Type
      • 9.3.3.2.3. By Technique
      • 9.3.3.2.4. By Application

10. South America Cell Separation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Cell Type
  • 10.2.3. By Technique
  • 10.2.4. By Application
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cell Separation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Cell Type
      • 10.3.1.2.3. By Technique
      • 10.3.1.2.4. By Application
  • 10.3.2. Colombia Cell Separation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Cell Type
      • 10.3.2.2.3. By Technique
      • 10.3.2.2.4. By Application
  • 10.3.3. Argentina Cell Separation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Cell Type
      • 10.3.3.2.3. By Technique
      • 10.3.3.2.4. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Cell Separation Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Akadeum Life Sciences, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Corning Inc.
• 15.3. Merck & Co., Inc.
• 15.4. STEMCELL Technologies Canada Inc.
• 15.5. Bio-Rad Laboratories, Inc.
• 15.6. Terumo Corp.
• 15.7. Becton, Dickinson and Company
• 15.8. Agilent Technologies, Inc.
• 15.9. Danaher Corporation
• 15.10. Thermo Fisher Scientific, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer